Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational
Official Title: Pharmacogenomics of Heparin-Induced Thrombocytopenia
Brief Summary: The purpose of this research is to identify genomic markers that can predict heparin-induced thrombocytopenia (HIT), which is a very serious side effect to heparin. Heparin is commonly used to prevent blood clots and the investigators may be able to identify genomic markers which can be used to prevent heparin use in people who will get HIT.